Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in ratsAudrey Hector(Centre Hospitalier de l’Université de Montréal), Jonathan Brouillette(Inserm)Alzheimer s Research & TherapyOctober 13, 202310.1186/s13195-023-01316-4Cited by 13SaveCiteExport RISWatch citationsRelated PapersNeurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model|Journal of Neuroscience|2012|171Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers|Scientific Reports|2020|50